Gen. Stanley McChrystal was confirmed by the Senate last week to be the new commander of U.S. (and NATO) forces in Afghanistan, a role that he assumed today. But his nomination was opposed by Sen. Russ Feingold (D-WI) who objected to the General’s advancement on unspecified “classified” grounds.
“I oppose the nomination of LTG Stanley McChrystal to command U.S. forces in Afghanistan for two reasons,” Senator Feingold said on June 11. “The first relates to a classified matter about which I have serious concerns. I have conveyed those concerns in a letter to the President.”
The second reason cited by Sen. Feingold was McChrystal’s embrace of interrogation techniques that went beyond those authorized in the Army Field Manual on the subject.
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.